Common
Nausea, Diarrhoea, Vomiting, Constipation, Weakness, Headache, Dizziness, Edema, Cold extremities, Numbness of extremity, Flushing (sense of warmth in the face, ears, neck and trunk), Decreased blood pressure, Slow heart rate.
Systonorm AT 5 mg/50 mg Tablet is a combination of two medicines: Amlodipine and atenolol which lower blood pressure effectively. Amlodipine is a calcium channel blocker which works by relaxing blood vessels while atenolol is a beta blocker that works specifically on the heart to slow down the heart rate. Together, they make the heart more efficient at pumping blood throughout the body.
Warnings
Alcohol
CAUTION
Atenolol and alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
Pregnancy
WEIGH RISKS VS BENEFITS
Systonorm AT 5 mg/50 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Lactation
CAUTION
Systonorm AT 5 mg/50 mg Tablet is probably usafe to use during lactation. Limited human data suggests that the drug could represent a significant risk to the baby.
Driving
Do not drive unless you are feeling well.
Systonorm AT 5 mg/50 mg Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Kidney
CAUTION
Systonorm AT 5 mg/50 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Systonorm AT 5 mg/50 mg Tablet may be needed. Please consult your doctor.
Regular monitoring of blood pressure is recommended and can help in better dose adjustment.
Liver
CAUTION
Systonorm AT 5 mg/50 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Systonorm AT 5 mg/50 mg Tablet may be needed. Please consult your doctor.
Systonorm AT 5 mg/50 mg Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.
